Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Study indicates a strong link between socio-economic status and asthma

New research shows Inuit populations in the Canadian Arctic have asthma rates far below Aboriginal people in other parts of Canada, especially those in urban centres.

4 May 2010

Despite FDA black box warning, prescription of Reglan for premature infants continue

Recently, researchers have observed a disturbing trend in neonatal units across the country: doctors prescribing Reglan -- also known by its generic name, metoclopramide -- to treat premature infants. This alarming development has raised serious concerns from many consumer safety advocates, particularly because the drug was never approved for use in infants.

4 May 2010

Rush Center for Urban Health Equity to focus on disparities in heart and lung disease

Rush University Medical Center has been awarded a $10 million grant from the National Institutes of Health to establish the Rush Center for Urban Health Equity. The aim of the Center is to find ways to promote changes to eliminate the disparities in heart and lung disease affecting inner city residents, in particular those who are low-income persons of color.

4 May 2010

NIAID researchers initiate trial of DAS181 in patients with asthma, bronchiectasis

NexBio, Inc. announced today the initiation of a trial of DAS181 (Fludase®) in patients with the respiratory conditions asthma and bronchiectasis, being conducted by researchers with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This trial will examine the effects of DAS181 in subjects with well-controlled or stable pulmonary disease.

3 May 2010

Santen licenses Clinical Data's ATL313 agonist compound for development of ophthalmic treatments

Clinical Data, Inc., and Santen Pharmaceutical Co., Ltd., today announced that Santen has exercised its option to license Clinical Data's highly selective adenosine A2A agonist compound, ATL313, for the development of topical treatments for certain ophthalmic diseases, including glaucoma. ATL313, a promising late-stage preclinical compound, has shown significant pharmacological effects in vivo and has been nominated as a clinical candidate.

From Santen Pharmaceutical Co., Ltd. 3 May 2010

Pfizer to maintain top spot in prescription sales through mergers and acquisitions

The rheumatoid arthritis treatment Humira will replace Lipitor as the world's biggest-selling drug in 2016, but a familiar name, Pfizer, will still be the biggest seller of medicines after the patent cliff according to the World Preview 2016 report published today by EvaluatePharma, the premier provider of pharma and biotech analysis.

3 May 2010

Researchers develop asthma medical home to care children with asthma

A comprehensive, patient-centered approach to asthma care that includes education, referrals to specialists and home visits not only improves patients' health but also has tremendous potential to decrease health care costs, according to research to be presented Saturday, May 1 at the Pediatric Academic Societies annual meeting in Vancouver, British Columbia, Canada.

3 May 2010

Exposure to violent crime may exacerbate asthma in children

Exposure to violent crime may exacerbate asthma in children, according to a study to be presented Saturday, May 1 at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.

3 May 2010

VIMOVO delayed-release tablets receive FDA approval

AstraZeneca and POZEN Inc. today announced the U.S. Food and Drug Administration has approved VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

3 May 2010

Rigel Pharmaceuticals receives 2010 Innovators Award of Excellence

Rigel Pharmaceuticals, Inc. has been named one of the recipients of the 2010 Innovators Award of Excellence by the San Mateo County Economic Development Association. The award will be presented at the association's Innovators luncheon today at the Oracle Conference Center in Redwood City.

30 Apr 2010

CDC report shows increase in seasonal flu vaccinations, greatest increase among children

More Americans were vaccinated against seasonal flu during the 2009-10 season (40 percent of eligible population) than during the previous flu season (33 percent of eligible population), according to a report by the Centers for Disease Control and Prevention.

30 Apr 2010

Male and female babies respond to stress during pregnancy differently

University of Adelaide research is showing that the sex of the baby determines the way it responds to stressors during pregnancy and its ability to survive pregnancy complications.

30 Apr 2010

Disability Rights Network of Pennsylvania files class action lawsuit against DPW

Disability Rights Network of Pennsylvania filed a class action lawsuit in U.S. District Court today against the Pennsylvania Department of Public Welfare alleging multiple violations of federal law in how DPW provides services to deaf persons with intellectual disabilities.

30 Apr 2010

TenX Biopharma signs Clinical Trial Agreement with NCI

TenX Biopharma, Inc., announced today it has signed a Clinical Trial Agreement with the National Cancer Institute to conduct an investigator sponsored Phase II clinical trial.

30 Apr 2010

Lotus Pharmaceuticals receives Chinese SFDA approval to commence Laevo-Bambuterol clinical trials

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China today reported that its innovative asthma drug Laevo-Bambuterol has received approval from China's State Food & Drug Administration's (SFDA) to commence clinical trials (No.2010L01309 and 2010L01399).

30 Apr 2010

SCOLR Pharma first-quarter total revenues decrease 3%

SCOLR Pharma, Inc. today reported financial results for the first three months ended March 31, 2010.

30 Apr 2010

Continuing education lectures on adult glioblastoma to be held at all U.S. healthcare centers

Adult glioblastoma continues to be a difficult disease to treat, so healthcare professionals must have the most up-to-date information regarding optimal methods for diagnostic imaging and treatment of these tumors. Awareness of novel agents in clinical trials is also critical to providing the best care.

30 Apr 2010

EndoChoice granted FDA marketing clearance for BONASTENT Esophageal and Biliary Stent platforms

EndoChoice, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its BONASTENT® Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions.

30 Apr 2010

Genetic test to predict newborns requiring hospital readmission shortly after birth

The results of two separate research studies taking place at Children's Mercy Hospitals and Clinics will help physicians use genetic testing to prevent complications, and ease the worry of new parents by predicting in advance which newborns may require readmission to the hospital shortly after birth. The studies also will help physicians identify which of their young patients are likely to respond well - or not - to steroid therapy for asthma.

29 Apr 2010

Most parents restrict playtime activities for asthmatic children

New data released today find that 82 percent of parents of children ages 4-12 with asthma report having restricted playtime activities to help avoid triggers and prevent asthma attacks in their children, with 47% of them keeping children with asthma inside when allergy season is in full swing. Working parents, who more often report experiencing stress related to raising a child with asthma than non-working parents (44% vs. 38%), take more precautions, such as more often swapping carpeting for wood flooring (30% vs. 17%).

29 Apr 2010

Asthma News and Research

Further Reading

Study indicates a strong link between socio-economic status and asthma

Despite FDA black box warning, prescription of Reglan for premature infants continue

Rush Center for Urban Health Equity to focus on disparities in heart and lung disease

NIAID researchers initiate trial of DAS181 in patients with asthma, bronchiectasis

Santen licenses Clinical Data's ATL313 agonist compound for development of ophthalmic treatments

Pfizer to maintain top spot in prescription sales through mergers and acquisitions

Researchers develop asthma medical home to care children with asthma

Exposure to violent crime may exacerbate asthma in children

VIMOVO delayed-release tablets receive FDA approval

Rigel Pharmaceuticals receives 2010 Innovators Award of Excellence

CDC report shows increase in seasonal flu vaccinations, greatest increase among children

Male and female babies respond to stress during pregnancy differently

Disability Rights Network of Pennsylvania files class action lawsuit against DPW

TenX Biopharma signs Clinical Trial Agreement with NCI

Lotus Pharmaceuticals receives Chinese SFDA approval to commence Laevo-Bambuterol clinical trials

SCOLR Pharma first-quarter total revenues decrease 3%

Continuing education lectures on adult glioblastoma to be held at all U.S. healthcare centers

EndoChoice granted FDA marketing clearance for BONASTENT Esophageal and Biliary Stent platforms

Genetic test to predict newborns requiring hospital readmission shortly after birth

Most parents restrict playtime activities for asthmatic children

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News